Detalhe da pesquisa
1.
TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes.
Br J Haematol
; 176(4): 600-608, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27984642
2.
ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.
Sci Adv
; 9(48): eadi7375, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019913
3.
Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.
Ann Hematol
; 91(12): 1879-86, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895556
4.
Bone marrow mesenchymal stem cells in myelodysplastic syndromes: cytogenetic characterization.
Acta Haematol
; 128(3): 170-7, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22890308
5.
The use of carbon monoxide breath test to detect the effect of iron overload on erythrocyte lifespan in MDS.
Front Oncol
; 12: 1058482, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523997
6.
Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.
Clin Epigenetics
; 13(1): 169, 2021 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461985
7.
Comparative Study on Iron Content Detection by Energy Spectral CT and MRI in MDS Patients.
Front Oncol
; 11: 646946, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828991
8.
Analysis of the influencing factors related to liver and cardiac iron overload in MDS patients detected by MRI in the real world.
Hematology
; 26(1): 123-133, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491605
9.
Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.
Front Oncol
; 10: 610525, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33520721
10.
Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation.
Front Genet
; 11: 603956, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33584800
11.
Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.
Leuk Res
; 58: 55-62, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28460338
12.
Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes.
Sci Rep
; 7: 43113, 2017 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28220884
13.
Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome.
Leuk Lymphoma
; 58(4): 969-978, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686004
14.
Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.
Am J Transl Res
; 9(2): 454-465, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28337274
15.
[Pathologic diagnosis of nonhematological tumor metastasis in bone marrow by marrow aspiration and trephine biopsy].
Zhonghua Bing Li Xue Za Zhi
; 39(2): 112-3, 2010 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-20388377
16.
Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.
Nat Commun
; 6: 8806, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26608094
17.
Cerebral venous and sinus thrombosis in a patient with acute promyelocytic leukemia during all-trans retinoic acid induction treatment.
Blood Coagul Fibrinolysis
; 25(7): 773-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24717424
18.
Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.
PLoS One
; 9(2): e88706, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24558415
19.
[Current understanding of iron overload hazard in patients with myelodysplastic syndrome].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 21(2): 484-8, 2013 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-23628060
20.
[Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 21(3): 678-83, 2013 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-23815921